Available NOW to buy, rent, or stream!
About BOMBARDIER BLOOD
Chris Bombardier has never let severe hemophilia stop him from climbing some of the world’s tallest mountains. In 2017, Chris partnered with hemophiliac filmmaker Patrick James Lynch and his award-winning production team at Believe Limited to film his journey through Nepal to summit the world’s tallest peak, Mount Everest.
In his home state of Colorado, filming captured Chris's training, interviews with Chris, his wife and family, and his hemophilia clinicians. In Nepal, production followed Chris to meetings with Nepalese hemophilia advocates and clinicians as well as to the homes of patients and families affected by the disease, where Chris heard the emotional stories of pain, suffering, and loss related to hemophilia. Production remained with Chris during his two months on Everest, capturing the physical, psychological, and emotional struggle of acclimating to the mountain and preparing for the greatest challenge of his life, all with the eyes of the global hemophilia community watching.
Leveraging powerful archival footage, the film also chronicles Chris's incredible six-year journey of climbing the Seven Summits, the highest mountain on each continent, during which he receives his "wake-up call" about hemophilia in developing countries and begins his activist mission.
In Nepal, as in nearly all developing nations, there is no routine access to healthcare and lifesaving medicine for people suffering from hemophilia. Bombardier Blood is an inspiring and heart-warming adventure film that cinematically highlights both what is and is not possible when living with this rare disease, depending on a patient's access to medicine and care.
DOWNLOAD OUR EPK
DOWNLOAD OUR PRESS RELEASE PDF
DOWNLOAD PHOTOS FOR PUBLICATION
Interested in hosting a screening of Bombardier Blood?
Send us a note and we’ll follow up with more info!
—
UPCOMING SCREENINGS
—
Check back often for more screening announcements!
ABOUT HEMOPHILIA
Hemophilia is a rare genetic bleeding disorder that affects approximately one in every 10,000 live births. It’s estimated there are around 400,000 people with hemophilia worldwide.
Of these, 70% have little access or no access to care; only 115,000 have even been diagnosed.
Hemophilia is caused by a missing protein in the blood. Hemophilia causes prolonged bleeding, and if left untreated, leads to joint deformities, agonizing pain, brain damage and in some cases death.
Half of all people with severe hemophilia in developing countries die before age 10.
Hemophilia is easily managed with injections of commercial blood-clotting medicine called factor.
Only 25% of people living with hemophilia in the world have access to treatment. Without the access to treatment, joint disease can occur at a young age, mobility is painful and difficult and life expectancy is extremely low. With treatment, patients with hemophilia live relatively active, well-rounded lives.
*Hemophilia statistics provided by World Federation of Hemophilia (WFH)
HEMOPHILIA IN NEPAL
Only 552 of the estimated 3,000 people with hemophilia are diagnosed.
The Nepal Hemophilia Society was founded in 1992.
Two central care units located in Central Kathmandu.
Six local chapters are located in different parts of Nepal.
Access to factor is limited and reliant entirely on international donations.
Prophylactic or preventative treatment is not available.
Save One Life offers direct, monthly financial aid to 118 families with hemophilia.
Five community members died in the 2015 earthquake; almost 60 lost all or parts of their homes.
Save One Life has been the only hemophilia organization to visit Nepal post-earthquake to assess the impact.